These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19442780)

  • 1. Pharmacy worker practices related to use of misoprostol for abortion in one Mexican state.
    Billings DL; Walker D; Mainero del Paso G; Clark KA; Dayananda I
    Contraception; 2009 Jun; 79(6):445-51. PubMed ID: 19442780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How often and under which circumstances do Mexican pharmacy vendors recommend misoprostol to induce an abortion?
    Lara D; García SG; Wilson KS; Paz F
    Int Perspect Sex Reprod Health; 2011 Jun; 37(2):75-83. PubMed ID: 21757422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacy workers in Nepal can provide the correct information about using mifepristone and misoprostol to women seeking medication to induce abortion.
    Tamang A; Puri M; Lama K; Shrestha P
    Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):104-15. PubMed ID: 25702074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Client-pharmacy worker interactions regarding medical abortion in Zambia in 2009 and 2011.
    Hendrickson C; Fetters T; Mupeta S; Vwallika B; Djemo P; Raisanen K
    Int J Gynaecol Obstet; 2016 Feb; 132(2):214-8. PubMed ID: 26604158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge and provision of misoprostol among pharmacy workers in Senegal: a cross sectional study.
    Reiss K; Footman K; Burke E; Diop N; Ndao R; Mane B; van Min M; Ngo TD
    BMC Pregnancy Childbirth; 2017 Jul; 17(1):211. PubMed ID: 28673342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacy provision of medical abortifacients in a Latin American city.
    Lara D; Abuabara K; Grossman D; Díaz-Olavarrieta C
    Contraception; 2006 Nov; 74(5):394-9. PubMed ID: 17046381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical abortion drug dispensing practices among private pharmacy workers in Nepal: A mystery client study.
    Sigdel A; Angdembe MR; Khanal P; Adhikari N; Maharjan A; Paudel M
    PLoS One; 2022; 17(11):e0278132. PubMed ID: 36417473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Availability and provision of misoprostol and other medicines for menstrual regulation among pharmacies in Bangladesh via mystery client survey.
    Huda FA; Ngo TD; Ahmed A; Alam A; Reichenbach L
    Int J Gynaecol Obstet; 2014 Feb; 124(2):164-8. PubMed ID: 24268354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misoprostol knowledge and distribution in Mexico City after the change in abortion law: a survey of pharmacy staff.
    Weaver G; Schiavon R; Collado ME; Küng S; Darney BG
    BMJ Sex Reprod Health; 2019 Nov; 46(1):46-50. PubMed ID: 31690579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacy Provision of Medication Abortion in Nepal: Pharmacy Owner and Worker Perspectives.
    Samari G; Puri M; Cohen R; Blum M; Rocca CH
    Int Perspect Sex Reprod Health; 2018 Sep; 44(3):81-89. PubMed ID: 30698524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stocking and over-the-counter sale of misoprostol for medical abortion in Ghana's community pharmacies: comparison of questionnaire and mystery client survey.
    Ganle JK; Busia NT; Baatiema L
    Int J Pharm Pract; 2020 Jun; 28(3):267-274. PubMed ID: 31746501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Provision of menstrual regulation with medication among pharmacies in three municipal districts of Bangladesh: a situation analysis.
    Huda FA; Mahmood HR; Alam A; Ahmmed F; Karim F; Sarker BK; Al Haque N; Ahmed A
    Contraception; 2018 Feb; 97(2):144-151. PubMed ID: 29175274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Availability and prescription of misoprostol for medical abortion in community pharmacies and associated factors in Accra, Ghana.
    Ganle JK; Busia NT; Maya E
    Int J Gynaecol Obstet; 2019 Feb; 144(2):167-173. PubMed ID: 30451283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacy workers' knowledge and provision of medication for termination of pregnancy in Kenya.
    Reiss K; Footman K; Akora V; Liambila W; Ngo TD
    J Fam Plann Reprod Health Care; 2016 Jul; 42(3):208-12. PubMed ID: 26869694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards safe abortion access: an exploratory study of medical abortion in Cambodia.
    Petitet PH; Ith L; Cockroft M; Delvaux T
    Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):47-55. PubMed ID: 25702068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and safety of early medication abortion provided in pharmacies by auxiliary nurse-midwives: A non-inferiority study in Nepal.
    Rocca CH; Puri M; Shrestha P; Blum M; Maharjan D; Grossman D; Regmi K; Darney PD; Harper CC
    PLoS One; 2018; 13(1):e0191174. PubMed ID: 29351313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, attitudes and knowledge of misoprostol for self-induction of abortion in women presenting for abortion at Midwestern reproductive health clinics.
    Kerestes C; Sheets K; Stockdale CK; Hardy-Fairbanks AJ
    Sex Reprod Health Matters; 2019 Dec; 27(1):1571311. PubMed ID: 31533561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of assessing the safety and effectiveness of menstrual regulation medications purchased from pharmacies in Bangladesh: a prospective cohort study.
    Footman K; Scott R; Taleb F; Dijkerman S; Nuremowla S; Reiss K; Church K
    Contraception; 2018 Feb; 97(2):152-159. PubMed ID: 28823841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and acceptability of a mifepristone-misoprostol combined regimen for early induced abortion among women in Mexico City.
    Peña M; Dzuba IG; Smith PS; Mendoza LJ; Bousiéguez M; Martínez ML; Polanco RR; Villalón AE; Winikoff B
    Int J Gynaecol Obstet; 2014 Oct; 127(1):82-5. PubMed ID: 24957534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, efficacy and acceptability of outpatient mifepristone-misoprostol medical abortion through 70 days since last menstrual period in public sector facilities in Mexico City.
    Sanhueza Smith P; Peña M; Dzuba IG; García Martinez ML; Aranguré Peraza AG; Bousiéguez M; Shochet T; Winikoff B
    Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):75-82. PubMed ID: 25702071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.